Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management

Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management

Introduction: Chronic Myeloid Leukemia (CML) is a myeloproliferative disease that affects mainly adults between 50 and 55 years. In Brazil, information from the Sistema Único de Saúde (SUS) Outpatient Information System indicates that 12,531 patients had the Autorização de Procedimento Ambulatorial...

Full description

Bibliographic Details
Main Authors: Carla Maria Boquimpani, André Neder Ramires Abdo, Denise Pires Martins, Luciana Britto de Abreu Lima, Mayde Seadi Torriani, Israel Bendit
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Chronic myeloid leukemia
PCR
Quantitative real-time
Reimbursement mechanisms
BCR-ABL
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920300559

Internet

http://www.sciencedirect.com/science/article/pii/S2531137920300559

Similar Items